1. Tofacitinib is associated with attainment of the minimally important reduction in axial magnetic resonance imaging inflammation in ankylosing spondylitis patients. (26th April 2018) Authors: Maksymowych, Walter P; Heijde, Désirée van der; Baraliakos, Xenofon; Deodhar, Atul; Sherlock, Sarah P; Li, David; Fleishaker, Dona; Hendrikx, Thijs; Kanik, Keith S Journal: Rheumatology Issue: Volume 57:Number 8(2018) Page Start: 1390 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗